Last edited by Tygoshicage
Tuesday, July 21, 2020 | History

5 edition of Anti-tuberculosis drug resistance in the world found in the catalog.

Anti-tuberculosis drug resistance in the world

third global report : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1999-2002

  • 35 Want to read
  • 5 Currently reading

Published by World Health Organization in Geneva .
Written in English

    Subjects:
  • Tuberculosis -- Prevention -- Statistics.,
  • Drug resistance -- Statistics.,
  • Tuberculosis, Multidrug-Resistant -- epidemiology -- Statistics,
  • Tuberculosis, Multidrug-Resistant -- prevention & control -- Statistics.

  • Edition Notes

    Other titlesWHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1999-2002
    Statement[written by Mohamed Abdel Aziz ... et al.].
    GenreStatistics., Statistics
    ContributionsAziz, Mohamed Abdel., WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.
    Classifications
    LC ClassificationsRA644.T7 A65 2004
    The Physical Object
    Pagination299 p. :
    Number of Pages299
    ID Numbers
    Open LibraryOL3463036M
    ISBN 109241562854
    LC Control Number2005424183
    OCLC/WorldCa58997053

    Dr Matteo Zignol, MD, MPH, is the Team Lead of the World Health Organization Global Project on Anti-Tuberculosis Drug resistance Surveillance, based in Geneva, Switzerland. He joined the World Health Organization in and his main areas of work are: surveillance of drug-resistant tuberculosis; interactions between epidemics of HIV and. Anti-Tuberculosis Drug Resistance in the World. World Health Organisation (WHO). This report presents the latest findings of a major collaborative study aimed at measuring the prevalence of anti-tuberculosis drug resistance throughout the world.

    Handbook of Anti-Tuberculosis Agents Global Alliance for TB Drug Development 80 Broad Street New York, NY , USA . drug resistance The resurgence of interest in tuberculosis has accelerated the world’s poorest populations, remains one of the. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance –Geneva, Switzerland: WHO. WHO. Anti-tuberculosis drug resistance in the world, report no.2, prevalence and trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.

    Development of anti-tuberculosis drug resistance can occur due to Mycobacterium tuberculosis genetic factor, previous anti-tuberculosis treatment-related factors and many other factors [].The mechanism of drug-resistance is shown in Figure is a constant rate of spontaneous mutation of mutations/deoxyribonucleic acid (DNA) replication that is unique for a Author: Attapon Cheepsattayakorn.   Drug-resistant TB has emerged as a major challenge facing TB prevention and control efforts. In Ethiopia, the extent/trend of drug resistance TB is not well known. The aim of this study was to determine the pattern and trend of resistance to first line anti-TB drugs among culture positive retreatment cases at ’s TB Specialized by:


Share this book
You might also like
What your congregation should know about the 1990 census.

What your congregation should know about the 1990 census.

works of John Milton

works of John Milton

The bright face of danger

The bright face of danger

Ill tell you what

Ill tell you what

Research in illustration

Research in illustration

Kano learnt his lesson (Childrens literature series)

Kano learnt his lesson (Childrens literature series)

Tropical exports and economic development

Tropical exports and economic development

Madisons music

Madisons music

disciplines denseignement general dans les programmes de lenseignement technique et professionel.

disciplines denseignement general dans les programmes de lenseignement technique et professionel.

Free remarks on Doctor Benjamin Trumbulls ... Appeal to the public relative to the unlawfulness of marrying a wifes sister

Free remarks on Doctor Benjamin Trumbulls ... Appeal to the public relative to the unlawfulness of marrying a wifes sister

British drama. --

British drama. --

The track

The track

Anti-tuberculosis drug resistance in the world Download PDF EPUB FB2

Anti tuberculosis drug resistance in the world Download anti tuberculosis drug resistance in the world or read online books in PDF, EPUB, Tuebl, and Mobi Format. Click Download or Read Online button to get anti tuberculosis drug resistance in the world book now. This site is like a library, Use search box in the widget to get ebook that you want.

Genre/Form: Statistics: Document Type: Book: All Authors / Contributors: Global Tuberculosis Programme.; WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.; WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance.

OCLC Number: Notes: "WHO/TB/" Description. This report presents the latest findings of a major collaborative study aimed at measuring the prevalence of anti-tuberculosis drug resistance throughout the world.

Drawing on data collected fromthe report covers the second phase of a global project organized by WHO, the International Union Against Tuberculosis and Lung Disease.

Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis. This fourth global report is based on information collected between and on 90 TB patients in 81 countries.

The objectives of the project were to measure the prevalence of anti-tuberculosis drug resistance in several countries world-wide using standard methods and to study the correlation between the level of drug resistance and treatment policies in those countries.

Get this from a library. Anti-tuberculosis drug resistance in the world. Report no. 2, Prevalence and trends. [WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance.;].

Anti-tuberculosis Drug Resistance in the World (The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance) [World Health Organization] on *FREE* shipping on qualifying offers.

Anti-tuberculosis Drug Resistance in the World (The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance)Author: World Health Organization. Request PDF | On Jan 1,M. Espinal and others published Anti-tuberculosis drug resistance in the world.

Report No. 2 | Find, read and cite all the research you need on ResearchGate. Drug resistance to the current major medications, the rifamycins and isoniazid, threatens to make tuberculosis untreatable for rising numbers of patients in many regions of the world.

Finding new, effective agents is essential to ensure cures for these cases and to halt transmission of multidrug-resistant tuberculosis to others. Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in fourth global report is based on information collected between and on 90, TB patients in published: 31 Mar, This is the third report of the WHO/IUATLD project which gives comparable worldwide information on anti-tuberculosis drug resistance, with data from surveys conducted in 77 different countries or geographical settings during the years to Global surveillance identifies areas of high resistance and draws the attention of national authorities to address the problems involved.

Discover the world's research. A pilot stability study on four-drug fixed-dose combination anti-tuberculosis products. Article. of anti-tuberculosis drugs, rifampicin (R) and isoniazid (H. Countries/settings with combined MDR TB prevalence rates higher than 10%, – From World Health Organization () Anti-tuberculosis Drug Resistance in the World: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance.

Report No.3, Prevalence and Trends, WHO/HTM/TB/ Resistance to at least one anti-tuberculosis drug ranged from 0% in three European countries to % in Tashkent, Uzbekistan.

The highest proportions of MDR-TB were reported in Tashkent (%) and Baku, Azerbaijan (%). data from Gujarat State, India, providing the first reliable descriptions of previously treated cases in India, showed 17 Cited by: 1. Anti-tuberculosis Drug Resistance in the World.

Fourth Global Report 作者: Not Available (NA) 副标题: The Who/Iuatld Global Project on Anti-tuberculosis Drug Resistance Surveillance 页数: 定价: 元 ISBN:   Anti-tuberculosis drug resistance in the world-Fourth global report, The WHO/IUATLD Global project on anti tuberculosis drug resistance surveillance (World Health Organization, Geneva).

pages. Price: CHF US$ ; in developing countries: CHF US $ ISBN Anti-tuberculosis drug resistance in the world. Report No. 4: The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. Author(s): World Health Organization.

Author Affiliation: Avenue Ap Gen Switzerland. Book: Anti. The trend in drug resistance against all first-line drugs shows a significant increase.

This remarkable percentage of drug resistance among retreatment patients supports the idea of inefficiency in TB control programs and irregular/improper anti-TB drug use in recent years, which have led to accumulation and multiplication of resistant by: More than 90 percent of newly detected culture-positive TB cases are now investigated for drug susceptibility in the Russian Federation.

The percentage of newly detected cases with resistance to any drug has increased in recent years, to 36 percent inwhile the resistance to any drug among relapsed cases rose to 54 percent in Available in the National Library of Australia collection.

Author: Wright, Abigail; Format: Book, Online; p.: col. ill., col. maps ; 24 cm. Inthe World Health Organization published its third report on surveillance of anti-tuberculosis drug resistance.

The prevalence of resistance to at least one anti-TB drug ranged from 0% in some high-income countries to % in Kazakhstan.Objective: To detect the infection and drug resistance of Mycobacterium tuberculosis (MTB) in Chongqing and provide a scientific basis for the prevention and treatment of tuberculosis.

Methods: DNA was collected from all new suspected patients in Chongqing from January to SeptemberGenechip technology was used to identify Mtb strain.

Genechip technology Author: Yishu Tang, Peiyang Song, Huiting Su. TB disease can be treated by taking several drugs for 6 to 9 months. There are 10 drugs currently approved by the U.S. Food and Drug Administration (FDA) for treating TB. Of the approved drugs, the first-line anti-TB agents that form the core of treatment regimens are: isoniazid (INH) ethambutol (EMB) pyrazinamide (PZA).